Outcomes of HeartMate 3 in pediatric patients with end-stage heart failure: a single-center preliminary experience from Turkey
ObjectivesWe aim to evaluate our initial experience with the HeartMate 3 (HM3) device (Abbott, USA) for palliating pediatric patients with end−stage heart failure (ESHF).MethodsWe conducted a retrospective review of clinical data from pediatric patients (aged 7–18 years) who underwent HM3 implantati...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2024-10-01
|
| Серии: | Frontiers in Cardiovascular Medicine |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1472663/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
